Natalie Kimura

Natalie Kimura is a business correspondent known for her in-depth interviews and feature articles. With a background in International Business and a passion for global economic affairs, Natalie has traveled extensively, providing her with a unique perspective on international trade and global market dynamics. She started her career in Tokyo, contributing to various financial journals, and later moved to London to expand her expertise in European markets. Natalie's expertise lies in international trade agreements, foreign investment patterns, and economic policy analysis.

Meta Capex Discipline vs Micron Memory Boom: Why the Market Cap Crossover Matters

Meta is the signal and Micron is the noise | investingLive Micron briefly surpassed Meta in market capitalization, and that crossover...

Consumer spending rises as cheaper gas promises relief

Consumer spending rises again - and now cheaper gas is on the way U.S. consumers kept the economy humming in May as spending grew faster...

2026 Toyota Hilux first drive: smarter, tougher and far more refined in Namibia

FIRST DRIVE | Testing the 2026 Toyota Hilux through Namibia Namibia can feel uncannily familiar to South Africans: wide horizons, flat scrubland, and crisp, well-marked...

How Solar Power Is Cutting Costs and Boosting Growth for Nigerian Businesses

Businesses turn to solar to cut energy costs Across Nigeria, more businesses are turning to solar energy to cut operating costs, stay productive during grid...

Labor tax reforms explained: CGT, negative gearing and SMSF borrowing changes

Everything you need to know about Labor's latest tax changes After a last‑minute agreement with the Greens, Parliament has passed wide‑ranging tax reforms that reshape...

How a Bootstrapped Wellness Brand Is Rethinking India’s Supplements Market

Bootstrapped at 50: How Purezen Is Quietly Rewriting India's Wellness Playbook | Startup Story Most people spend their fifties winding down. Mitesh Desai spent his...

Cred Raises $900 Million as Founder Moves to WhatsApp: What Happens Next for the Fintech Startup

Cred Gets $900 Mn and Loses Its Founder: What Comes Next for the Fintech Startup Cred has entered a pivotal new phase: the fintech platform...

AbbVie Deepens Immunology Push With $11B Apogee Deal and Long-Dosing Eczema Therapy

AbbVie’s $11B Apogee Acquisition Brings an Eczema Drug With an Edge AbbVie is expanding its immunology leadership with a deal to acquire Apogee Therapeutics for...

Join our community of SUBSCRIBERS and be part of the conversation.

To subscribe, simply enter your email address on our website or click the subscribe button below. Don't worry, we respect your privacy and won't spam your inbox. Your information is safe with us.